List view / Grid view
11 May 2017 | By Niamh Marriott, Junior Editor
The EBM, a non-profit organisation for life-threatening blood cancers and diseases, will implement Elsevier’s MACRO platform to support patient registry...
10 May 2017 | By Niamh Marriott, Junior Editor
Canadian physicians are being advised to reduce their prescribing of opioid medication to patients with chronic non-cancer pain in a new guideline...
10 May 2017 | By Niamh Marriott, Junior Editor
This follows the initiation of the Phase IIb trial by Conatus evaluating emricasan in patients with decompensated liver cirrhosis caused by NASH...
Ashfield Healthcare Communications, a global healthcare communications agency, announces significant growth across the UK and Europe.
9 May 2017 | By Syrris
Syrris is launching its revolutionary Titan system at InformEX in Philadelphia, USA, from the 16th to the 18th of October...
9 May 2017 | By Niamh Marriott, Junior Editor
Ireland has stepped up its bid to host the European Medicines Agency (EMA) with the official announcement being delivered and reiterated bySimon Harris...
9 May 2017 | By University of Leeds
Data from a new device demonstrates maximal levels of extensional flow which manufacturers could use for different processes, without damaging proteins...
8 May 2017 | By Niamh Marriott, Junior Editor
bioLytical Laboratories has developed the INSTI HIV Self Test following research revealing that over 103,000 people are living with HIV in the UK...
Customised vibrating separator increases productivity and product quality for pharmaceutical filler manufacturer.
8 May 2017 | By Niamh Marriott, Junior Editor
Braeburn Pharmaceuticals’ 6-month study of the safety, tolerability and pharmacokinetics of transferring patients diagnosed with schizophrenia...
8 May 2017 | By Niamh Marriott, Junior Editor
Aptar Pharma’s dispensing technologies combined with Kali Care’s smart sensors, data analytics and cloud services will make clinical trials more efficient.
5 May 2017 | By Niamh Marriott, Junior Editor
The FDA has approved Roche’s biomarker assay as a complementary diagnostic to provide PD-L1 status for patients with urothelial carcinoma...
5 May 2017 | By Niamh Marriott, Junior Editor
Braeburn Pharmaceuticals and Camurus announced positive results from Phase 3 trial supporting the safety and efficacy of CAM2038 in opioid use disorder...
5 May 2017 | By
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the adoption of AstraZeneca’s Brilique (ticagrelor) 90mg orodispersible tablets (ODT) as a new method of treatment administration. This opinion is the first step towards the adoption of a new…
5 May 2017 | By Cherwell Laboratories
Cherwell Laboratories will be exhibiting at the Clinical Pharmacy Congress...
